Stay updated on Niraparib vs Placebo Maintenance in Platinum-Sensitive Ovarian Ca Clinical Trial
Sign up to get notified when there's something new on the Niraparib vs Placebo Maintenance in Platinum-Sensitive Ovarian Ca Clinical Trial page.

Latest updates to the Niraparib vs Placebo Maintenance in Platinum-Sensitive Ovarian Ca Clinical Trial page
- Check2 days agoChange Detected- The government funding lapse notice banner was removed from the page. Core study content and data remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe two screenshots show the same study details page with no visible additions or deletions. Overall layout and content appear unchanged.SummaryDifference0.2%

- Check46 days agoChange DetectedPage now shows a new revision tag v3.2.0 and removes a reference to Ovarian cancer under Genetic and Rare Diseases Information Center resources, plus removes an older revision tag v3.0.2.SummaryDifference0.1%

- Check47 days agoChange DetectedSummary of changes: added version tag v3.1.0; removed Ovarian cancer resource and old version tag v3.0.2.SummaryDifference0.1%

- Check54 days agoChange DetectedThe page has removed key safety and quality sections (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs), reducing core content related to drug quality and safety.SummaryDifference0.1%

- Check61 days agoChange DetectedPage revision updated to v3.0.2; the previous v3.0.1 revision tag was removed along with the 'Back to Top' link.SummaryDifference0.1%

Stay in the know with updates to Niraparib vs Placebo Maintenance in Platinum-Sensitive Ovarian Ca Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Niraparib vs Placebo Maintenance in Platinum-Sensitive Ovarian Ca Clinical Trial page.